SK Life Science Labs, a subsidiary of SK Biopharmaceuticals Co., Ltd., has announced a major advancement in oncology with the discovery of PVTX-405, a potent ...

“His leadership in design and discovery of life-changing ... newly appointed Chief Scientific Officer at Zealand Pharma, added, “The recent advances in data science and machine learning ...

Dr. Abraham brings over three decades of experience leading scientific and translational efforts in oncology and joins Engine as the company advances its drug discovery and development programs.

Kewaunee Scientific Corp ... investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education ...

Singh will lead the discovery and clinical translation of peptide medicines, investing in new technologies, including data and computational science.

No. 5 / 2025 Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics ...